Category: Cancer Treatment

Entrepreneurial and Philanthropic Life Of Eric Lefkofsky

Born on the 2nd of September 1969, Eric Lefkofsky is an entrepreneur from the United States of America. He spent his childhood in Michigan and attended Southfield-Lathrup High school and later graduated from University of Michigan in 1991 with honors. He then continued with law studies at the same university and graduated in 1993.

Brief Entrepreneurial History

Eric began his entrepreneurial life as a carpet seller in University of Michigan. It was after his graduation from law school that Eric Lefkofsky and his college friend started up their first company. This made the debut of the founding of his many businesses Eric Lefkofsky is one of the co-founders and also the chief executive officer (CEO) of Tempus. In addition to this, he also happens to among the co-founders of Groupon, Echo Global Logistics and also Lightbank, which a Chicago-based capital firm.

About Tempus

Tempus is a technology-based company which has built an OS (Operating system) to help battle cancer. He quit his chief executive officer role at Groupon so that he could work on Tempus. This is a health technology startup that is building infrastructure to help bring up to date cancer treatment. The role of the company is to assist doctors and other healthcare specialists to come up with real-time, data-driven and individualized patient treatment and management decisions after the analysis of the given patient’s genetic code.Eric Lefkofsky partnered with Brad Keywell in initiating Tempus. Eric and Brad have a lot in common. There are so many businesses they run together. They always spend quality time identifying solutions for problems they might be experiencing. Their corporate duty in determining viable remedies for problems affecting them has taken them a long way in impacting societies.

Eric’s Philanthropic Activities

Lefkofsky Family Foundation is a private philanthropic foundation which was established by Eric Lefkofsky and his wife in 2006. The foundation was created so as to aid in the advancement of high-impact projects which usually enhance the lives of the people in the communities that they serve. It is through this foundation that Lefkofsky and his wife have been able to give regular donations to cancer research centers and causes. At Lurie Children’s Hospital in Chicago, Lefkofsky is also a trustee.

Enhancement of Cancer Treatment with Clay Siegall

Clay Siegall got his a Ph.D in Genetics from George Washington University and also B.S in Zoology from the University of Maryland. He is a well-accomplished businessman and scientist. For over the years he has worked in the biotechnology industry hence attaining a lot of experience. Additionally he was given an award for being among the 2013 Alumnus of the year for computer, Natural sciences and Math from the University of Maryland. Clay Siegall started Seattle Genetic is a company in the year 1998. He is the CEO and the President of the company. He also is the chairman of the board of members at the company

Biotechnology deals with the making of technology in the world of science or it is the usage of many microorganisms to carry out particular engineering procedures in order to provide artificial hormones and drugs. Seattle Genetic end goals to the cancer patients are to provide the best antibody drug conjugates (ADC) and also proper service to patients as a biotechnology company. Clay Siegall and his staffs guarantee that they work hard in order to assist the patients with cancer to attain treatment they need. The company first product was Adcetric which has reached over 60 countries all over the universe.

The economical rate of the company has risen due to Clay Siegall and his team effort through hard work and dedication they keep doing. Through his expertise and experience it has managed to position more than 20 ADCs of the company’s understanding in several clinical developments. The company private and public economic status has approximately attained $330 million in over the years. Patients who have Lymphoma who are more than 15,000 in various countries have been cured with Adcetris.

Seattle Genetic has other products such as SGN-CD19A in non-Hodgkin lymphoma and SGN-CD33A in acute myeloid leukemia that are used in medicals. Clay Siegall is fascinated with the good effects of the cures. He and the corporation they are certain that there will be advanced treating therapies in the future to improve the lives of cancer patients. Clay Siegall and the company have joined together with various other companies to enhance the therapies of cancer treatment.